We foreground this as it is highly significant in light of the drive towards a single market for medicines, both in terms of the public debate it sparks and when comparing the current iteration with the initial Commission proposals.
← all excerpts
Constructing a single market for pharmaceuticals in the EU: what's the price?
1
—
—